BDSX logo
Biodesix, Inc.(BDSX)
Updated 11:58 AM ESTAbout this dataData status
$10.56▲0.44 (4.35%)

Consensus

Buy4.00 / 55 ratings · Buy 5

Price vs analyst targets

Revenue and EPS estimates

ReportedConsensus estimates
Fiscal periodFY2023Dec '23FY2024Dec '24FY2025Dec '25FY2026Dec '26FY2027Dec '27FY2028Dec '28FY2029Dec '29FY2030Dec '30
Revenue (M)49.171.388.5106.4128.5150.6176.5201.5
Growth YoY+28.5%+45.2%+24.1%+20.2%+20.7%+17.2%+17.2%+14.2%
High estimate–––106.6137.3152.9184.4210.6
Low estimate–––106.0124.9148.4172.3196.7
Analysts–––56312
EPS, adjusted−12.95−7.00−4.85−2.83−1.80−1.01−0.340.24
Growth YoYn/mn/mn/mn/mn/mn/mn/mn/m
High estimate–––−2.70−1.63−0.72−0.330.25
Low estimate–––−3.06−2.04−1.40−0.360.23
Analysts–––55311

Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.

Brokers

6 firms active in the last 12 months
FirmAnalystRatingPrev ratingTargetPrev targetChgUpsideDate
HC Wainwright & Co.–BuyBuy$38.00$26.00+46%+277%Nov 9
Lake Street–BuyBuy––––Nov 6
TD Cowen–BuyBuy––––Oct 13
Canaccord GenuityKyle MiksonBuyBuy$35.00$27.00+30%+247%Aug 10
Roth CapitalMax Masucci––$32.00––+217%Jun 24
William Blair–OutperformMarket Perform––––Feb 27

Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.